You are here
Award Data
The Award database is continually updated throughout the year. As a result, data for FY24 is not expected to be complete until March, 2025.
Download all SBIR.gov award data either with award abstracts (290MB)
or without award abstracts (65MB).
A data dictionary and additional information is located on the Data Resource Page. Files are refreshed monthly.
The SBIR.gov award data files now contain the required fields to calculate award timeliness for individual awards or for an agency or branch. Additional information on calculating award timeliness is available on the Data Resource Page.
-
GPCR antagonists as anti-Ebola virus entry inhibitors
SBC: MICROBIOTIX, INC. Topic: RDESCRIPTION provided by applicant Ebola EBOV and Marburg MARV viruses belong to the family Filoviridae and can cause fatal hemorrhagic fevers characterized by widespread tissue destruction with an incubation period of days Because of the safety concerns these viruses are designated as biosafety level agents Currently there is no effective vaccine or therapeutic treatment against f ...
STTR Phase I 2015 Department of Health and Human ServicesNational Institutes of Health -
ASTROCYTE ACTIVATION BY SMALL MOLECULE P2Y1 AGONISTS FOR TREATMENT OF TBI
SBC: ASTROCYTE PHARMACEUTICALS INC. Topic: 105DESCRIPTION provided by applicant Traumatic brain injuries TBI are an area of significant unmet need with no approved therapeutics and a national burden of $ billion annually Astrocyte Pharmaceuticals is developing a small molecule pharmaceutical agent that would be administered by intravenous injection by emergency responders or a medical professional within hours of injury to limit n ...
STTR Phase I 2015 Department of Health and Human ServicesNational Institutes of Health -
Phase IIB: Portable Device for Telecare Monitoring of Elderly People
SBC: BIOSENSICS LLC Topic: NIADESCRIPTION provided by applicant We propose to further develop field test and commercialize a reliable and robust sensor technology that allows the objective assessment of daily physical activity risk of falling frailty and activity organization among older adults in he home and community This is a Phase IIB STTR application During Phases Iandamp II BioSensics LLC in collaboration wit ...
STTR Phase II 2015 Department of Health and Human ServicesNational Institutes of Health -
Novel filovirus entry inhibitors based on a pseudo-symmetrical biphenyl core
SBC: MICROBIOTIX, INC. Topic: RDESCRIPTION provided by applicant Ebola EBOV and Marburg MARV viruses belong to the family Filoviridae and can cause fatal hemorrhagic fevers characterized by widespread tissue destruction with an incubation period of days Because of the safety concerns these viruses are designated as biosafety level agents Currently there is no effective vaccine or therapeutic treatment against f ...
STTR Phase I 2015 Department of Health and Human ServicesNational Institutes of Health -
Lipoprotein synthesis inhibitors for multi-drug resistant Gram-negative therapy
SBC: MICROBIOTIX, INC. Topic: NIAIDDESCRIPTION provided by applicant The increasing prevalence of drug resistant bacterial infections highlights the critical medical need for new agents that are not susceptible to existing resistance mechanisms Few new agents are in development for Gram negative bacteria which take up small molecules sparingly and efflux most compounds that reach the periplasm A particularly problematic group ...
STTR Phase I 2015 Department of Health and Human ServicesNational Institutes of Health -
A novel drug detection assay using fluorescent biosensor technology
SBC: GLSynthesis Inc. Topic: 300DESCRIPTION provided by applicant This phase project has as its overall objectives to design engineer optimize and implement a novel genetically encoded fluorescent drug sensor FDS based on F rster Resonance Energy Transfer FRET by exploiting conformational rearrangements induced by drug interactions with human serum albumin SA SA is uniquely suited for a general drug sensor beca ...
STTR Phase I 2015 Department of Health and Human ServicesNational Institutes of Health -
Cloud quantitative imaging for whole-body tumor burden in neurofibromatoses
SBC: IQ MEDICAL IMAGING LLC Topic: 102DESCRIPTION provided by applicant The neurofibromatoses NFs including NF NF and schwannomatosis are a group of autosomal dominant neurogenetic disorders characterized by a predisposition in virtually of patients to develop multiple nerve sheath tumors The determination of tumor burden on magnetic resonance imaging MRI images is crucial for the management of NF patients which is ...
STTR Phase I 2015 Department of Health and Human ServicesNational Institutes of Health -
Microscale Detector Materials for Covert, Ubiquitous Radiation Detector
SBC: RADIATION MONITORING DEVICES, INC. Topic: DTRA14B004The proliferation of nuclear and radiological weapons of mass destruction is a serious threat in the world today. The goal of this proposal is to develop a new, very low cost radiation detection technology that will be useful for detection and for surveillance of individuals who have been near radioactive materials. The technology can also be used for dosimetry, and will provide the technology for ...
STTR Phase I 2015 Department of DefenseDefense Threat Reduction Agency -
Improved Performance of Neonatal Vascular Access Catheters via 3D Magnetic Printing
SBC: N2 Biomedical, LLC Topic: NICHDDESCRIPTION provided by applicant Clinical treatment of infants in the neonatal intensive care unit NICU is particularly challenging due to their small anatomies medical instability and immature physiological processes Treatment is often complicated by the lack of therapeutic devices and instrumentation designed specifically to accommodate this unique patient population For instance curr ...
STTR Phase I 2015 Department of Health and Human ServicesNational Institutes of Health -
Identification of patients with diabetes at high risk for treatment failure
SBC: LP INFORMATION TECHNOLOGY INC. Topic: 200DESCRIPTION provided by applicant The overall goal of this project is to improve quality of care of patients with diabetes by identifying patients who may have particular difficulty reaching treatment targets and who could therefore potentially benefit from additional resources Investigators propose to achieve this goal by developing a technology to accurately identify patients at high risk f ...
STTR Phase I 2015 Department of Health and Human ServicesNational Institutes of Health